TENACI-T THERAPEUTICS LLC — Department of Health and Human Services SBIR: FY2025 SBIR CONCEPT CLEARANCE AWARD FOR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE T
TENACI-T THERAPEUTICS LLC — SBIR award from Department of Health and Human Services.
SBIR award competitive context
- Public SBIR obligation from Department of Health and Human Services to TENACI-T THERAPEUTICS LLC. Use agency + tech-domain links below to map the broader competitive field.
- Obligated amount $297,621. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Tenaci-T Therapeutics LLC received nearly $300,000 from the National Institutes of Health to develop new therapies or preventatives for pediatric and rare cancers. This SBIR award supports early-stage research on treatments for these specific cancer types.
- Amount
- $297,621
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- TX
- Period
- 2025-09-17 → 2027-09-16
Technology domains
Description
FY2025 SBIR CONCEPT CLEARANCE AWARD FOR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS.